BB Biotech AG's Form 4 filing
Molecular Templates, Inc. (MTEM) · filed Jul 28, 2021
- Accession no.
- 0000899243-21-030317
- Filed
- Jul 28, 2021, 12:23 PM ET
- Trade date
- Jul 26-27, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BB Biotech AGCIK 0000924223 | 10% Owner |
| Biotech Target N VCIK 0001259870 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2021 | Common Stock | PPurchaseAcquired | +80,000 | $7.00 | +$559,816 | 9,867,003 | Direct | |
| Jul 27, 2021 | Common Stock | PPurchaseAcquired | +75,000 | $7.09 | +$531,840 | 9,942,003 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.